Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Mallinckrodt Pharmaceuticals
Sort By
Newest First
1 / 1
1 / 1
Transaction
Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million
BIOVECTRA
PR-M09-19-NI-037
Sep 13, 2019
M&A
Mallinckrodt and Silence Therapeutics Announce Collaboration to Develop And Commercialize RNAi Therapeutics for Complement-Mediated Diseases
Mallinckrodt Pharmaceuticals
PR-M07-19-NI-059
Jul 23, 2019
Generics
Mallinckrodt Modifies Specialty Generics Spinout Portfolio Composition
Nice Insight
PAO-M06-19-NI-004
Jun 13, 2019
Generics
Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders
Mallinckrodt Pharmaceuticals
PR-M05-19-NI-087
May 31, 2019
Research
Mallinckrodt Presents Data on Cutaneous T-cell Lymphoma at 2019 American Academy of Dermatology Annual Meeting
Mallinckrodt Pharmaceuticals
PR-M03-19-NI-013
Mar 06, 2019
Spin-off Business
Mallinckrodt Spins off its Generics Business
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-005-11
Dec 11, 2018
Rheumatology
Mallinckrodt Presents Data on H.P. Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2018 ACR/ARHP Annual Meeting
Mallinckrodt Pharmaceuticals
PR-M10-18-NI-092
Oct 26, 2018
Skin Graft
Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns
Mallinckrodt Pharmaceuticals
PR-M10-18-NI-063
Oct 18, 2018
Licensing Agreement
Cancer Prevention Pharmaceuticals Completes North American Licensing Deal with Mallinckrodt
Cancer Prevention Pharmaceuticals
PR-M09-18-NI-008
Sep 05, 2018
Collaborative Research Partnership
Mallinckrodt Forms Collaborative Research Partnership with Washington University in St. Louis
Mallinckrodt Pharmaceuticals
PR-M08-18-NI-056
Aug 14, 2018
Clinical Data
Mallinckrodt Rheumatoid Arthritis Phase 4 Clinical Study for H.P. Acthar® Gel (Repository Corticotropin Injection) Achieves its Enrollment Target
Mallinckrodt Pharmaceuticals
PR-M07-18-NI-009
Jul 03, 2018
Scientific Advisory Council
Mallinckrodt Launches Scientific Advisory Council
Mallinckrodt Pharmaceuticals
PR-M06-18-NI-081
Jun 25, 2018
FDA Acceptance
Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing
Mallinckrodt Pharmaceuticals
PR-M02-18-NI-106
Feb 28, 2018
Clinical Trials
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft™C9T1 Skin Tissue
Mallinckrodt Pharmaceuticals
PR-M02-18-NI-74
Feb 20, 2018
Acquisition
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
PR-M02-18-NI-62
Feb 16, 2018
Acquistion
Mallinckrodt Expands Rare Disease Pipeline with Sucampo Acquisition
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-18-NI-017
Jan 11, 2018
Acquisition
Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy
Nice Insight
PAO-M11-17-NI-020
Nov 10, 2017
Acquisition
Mallinckrodt Acquires InfaCare Pharmaceutical Corporation for $425 Million
Nice Insight
PAO-M08-17-NI-023
Aug 17, 2017
